Kelly Michael Aaron
CIK 0001769668
Director
Filings
22
Latest Jun 3, 2026
Issuers covered
4
Showing
22 of 22
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -4.5% | -4.5% | -4.5% | -4.5% |
| 90 days | 1 | 0% | -14.0% | -14.0% | -14.0% | -14.0% |
| 180 days | 1 | 100% | +54.8% | +54.8% | +54.8% | +54.8% |
| 365 days | 1 | 100% | +27.6% | +27.6% | +27.6% | +27.6% |
Issuers
Companies where Kelly Michael Aaron has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NEO | Neogenomics Inc | 7 | Jun 3, 2026 |
| BOOM | Dmc Global Inc. | 6 | May 14, 2026 |
| FOLD | Amicus Therapeutics, Inc. | 5 | Apr 27, 2026 |
| PRME | Prime Medicine, Inc. | 4 | Aug 5, 2025 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|